Back
Day Range
$97.00
$101.45
52-Week Range
$55.00
$169.90
Volume
200
50D / 200D Avg
$140.81
/
$98.97
Prev Close
$95.19
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -452.4 | 0.4 |
| P/B | 3.4 | 2.9 |
| ROE % | -0.7 | 3.7 |
| Net Margin % | -3.5 | 3.8 |
| Rev Growth 5Y % | 12.7 | 10.0 |
| D/E | 0.0 | 0.2 |
Key Takeaways
Revenue grew 12.66% annually over 5 years — strong growth
Earnings declined -102.72% over the past year
Debt/Equity of 0.01 — conservative balance sheet
Negative free cash flow of -15.84M
Revenue growth is decelerating — 1Y growth trails 5Y average by 73.37%
Capital efficient — spends only 4.04% of revenue on capex
Growth
Revenue Growth (5Y)
12.66%
Revenue (1Y)-60.71%
Earnings (1Y)-102.72%
FCF Growth (3Y)N/A
Quality
Return on Equity
-0.74%
ROIC-1.62%
Net Margin-3.46%
Op. Margin-10.00%
Safety
Debt / Equity
0.01
Current Ratio7.18
Interest Coverage-57.54
Valuation
P/E Ratio
-452.43
P/B Ratio3.41
EV/EBITDAN/A
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -60.71% | Revenue Growth (3Y) | 6.29% |
| Earnings Growth (1Y) | -102.72% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 12.66% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 104.82M | Net Income (TTM) | -3.63M |
| ROE | -0.74% | ROA | -0.59% |
| Gross Margin | 46.53% | Operating Margin | -10.00% |
| Net Margin | -3.46% | Free Cash Flow (TTM) | -15.84M |
| ROIC | -1.62% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.01 | Current Ratio | 7.18 |
| Interest Coverage | -57.54 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | -452.43 | P/B Ratio | 3.41 |
| P/S Ratio | 15.67 | PEG Ratio | 4.84 |
| EV/EBITDA | N/A | Dividend Yield | 0.02% |
| Market Cap | 1.64B | Enterprise Value | 1.59B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 104.82M | 266.79M | 92.78M | 102.09M | 65.07M |
| Net Income | -3.63M | 133.24M | -4.93M | 17.23M | 21.67M |
| EPS (Diluted) | -0.23 | 8.12 | -0.31 | 1.05 | 1.28 |
| Gross Profit | 48.77M | 246.92M | 53.44M | 83.33M | 49.93M |
| Operating Income | -10.48M | 148.88M | 6.15M | 28.06M | 11.10M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 611.97M | 646.77M | 553.98M | 759.59M | 805.56M |
| Total Liabilities | 123.32M | 141.68M | 124.94M | 295.80M | 292.88M |
| Shareholders' Equity | 481.78M | 498.33M | 422.16M | 456.93M | 505.28M |
| Total Debt | 4.26M | 2.20M | 1.84M | 173.60M | 169.92M |
| Cash & Equivalents | 55.80M | 44.30M | 50.28M | 185.83M | 198.56M |
| Current Assets | 183.08M | 202.26M | 102.23M | 306.10M | 275.85M |
| Current Liabilities | 25.49M | 48.27M | 25.71M | 194.95M | 21.24M |